Skip to main content
Advertisement
Advertisement
PBH
PBH logo
Prestige Consumer Healthcare Inc.
49.60
USD
Sponsored
-1.02
-2.02%
Nov 19, 15:59 UTC -5
Closed
exchange

After-Market

49.65

+0.05
+0.10%

Prestige Consumer Healthcare Inc. (PBH) Earnings

PBH Earnings Reports

Positive Surprise Ratio

PBH beat 33 of 43 last estimates.

77%

Next Report

Date of Next Report
Feb 03, 2027
Estimate for Q3 27 (Revenue/ EPS)
$331.30M
/
$1.06
Implied change from Q2 27 (Revenue/ EPS)
-1.49%
/
-5.36%
Implied change from Q3 26 (Revenue/ EPS)
+16.89%
/
-6.19%

Prestige Consumer Healthcare Inc. earnings per share and revenue

On Nov 05, 2026, PBH reported earnings of 1.12 USD per share (EPS) for Q2 27, beating the estimate of 1.08 USD, resulting in a 4.28% surprise. Revenue reached 336.31 million, compared to an expected 332.42 million, with a 1.17% difference. The market reacted with a -16.82% price change (close before vs. close after earnings).
Looking ahead to Q3 27, -- analysts forecast an EPS of 1.06 USD, with revenue projected to reach 331.30 million USD, implying an decrease of -5.36% EPS, and decrease of -1.49% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%
logo
Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
-$0.16
Surprise
-361.44%
logo
Oramed Pharmaceuticals Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.43
Actual
$0.43
Surprise
-1.96%
logo
MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%
logo
Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%
logo
Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-
Actual
$0.10
Surprise
-
logo
FitLife Brands, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.24
Actual
$0.16
Surprise
-34.64%
logo
Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%
logo
Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%
logo
Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%
FAQ
For Q2 2027, Prestige Consumer Healthcare Inc. reported EPS of $1.12, beating estimates by 4.28%, and revenue of $336.31M, 1.17% above expectations.
The stock price moved down -16.82%, changed from $53.28 before the earnings release to $44.32 the day after.
The next earning report is scheduled for Feb 03, 2027.
Based on -- analysts, Prestige Consumer Healthcare Inc. is expected to report EPS of $1.06 and revenue of $331.30M for Q3 2027.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement